Genzyme Reports Financial Results for the Second Quarter of 2010
Links shared publicly online about this topic.
- 1,006total visits
Genzyme Reports Financial Results for the Second Quarter of 2010
View full resource at businesswire.com
Tags: Gaucher Disease Medication, Cerezyme, Genzyme
Most Recently Shared on July 21, 2010 at 2:08 pm By:
Genzyme Reports Financial Results for the Second Quarter of 2010 http://bit.ly/9lVns7
Genomic Health Announces Q2 2011 Financial Results | IVD Technology
ivdtechnology.com — “Genomic Health Inc. reported financial results and business progress for the quarter ended June 30, 2011. Total revenue increased to $50.8 million in the second quarter of 2011, compared with $43.4 million in the second quarter of 2010. Product revenue was $50.5 million in the second quarter of 2011, an increase of 19%, compared with $42.5 million in the second quarter of 2010.” View full resource at ivdtechnology.com
Most Recently Shared on August 4, 2011 at 6:35 pm By:
IVD Technology Health Magazine
Genomic Health Announces Q2 2011 Financial Results http://tinyurl.com/3ce4bw9
ARIAD reports $47.8 million net loss for second quarter 2011
news-medical.net — “ARIAD Pharmaceuticals, Inc. today reported financial results for the second quarter and six months ended June 30, 2010 and provided an update on corporate developments.” View full resource at news-medical.net
Most Recently Shared on August 2, 2011 at 1:24 pm By:
ARIAD reports $47.8 million net loss for second quarter 2011: ARIAD Pharmaceuticals, Inc. today reported financi... http://bit.ly/nMz6EQ
Genzyme Reports Financial Results for Fourth Quarter of 2010 and Full Year - Drugs.com MedNews
drugs.com — “Recovery Continues with Growth Across All Businesses Feb 16, 2011 - Genzyme Corp. (NASDAQ GENZ) today reported fourth-quarter 2010 results that reflect increasi” View full resource at drugs.com
Most Recently Shared on February 16, 2011 at 2:13 pm By:
Drugs and Devices OW OW Health
Genzyme Reports Financial Results for Fourth Quarter of 2010 and Full Year: Recovery Continues with Growth... http://bit.ly/fk5Cyf #drug
Genzyme Reports Financial Results for Fourth Quarter of 2010 and Full Year | Business Wire
businesswire.com — “Genzyme Corp. (NASDAQ: GENZ) today reported fourth-quarter 2010 results that reflect increasing supplies of Cerezyme® (imiglucerase for injection)” View full resource at businesswire.com
Most Recently Shared on February 16, 2011 at 1:30 pm By:
Genzyme Reports Financial Results for Fourth Quarter of 2010 and Full Year http://bit.ly/eaHU23
AngioDynamics books positive Q2
healthimaging.com — “AngioDynamics, a developer of medical devices for the minimally-invasive treatment of cancer and peripheral vascular disease, has reported slightly higher net income in its financial results for the fiscal 2011 second quarter, which ended Nov. 30, 2010.” View full resource at healthimaging.com
Most Recently Shared on January 11, 2011 at 4:25 am By:
Health Imaging & IT Health Magazine
AngioDynamics books positive Q2 - AngioDynamics, a developer of medical devices for the minimally-invasive treatmen... http://ow.ly/1aOwtG
Cambridge Heart second quarter 2010 total revenue decreases 18%
news-medical.net — “Cambridge Heart, Inc., today reported results for the three and six months ended June 30, 2010. Full financial statements and corresponding commentary can be found in the Company's Form 10-Q, which is expected to be filed with the Securities and Exchange Commission on August 16, 2010.” View full resource at news-medical.net
Most Recently Shared on August 17, 2010 at 5:06 pm By:
Cambridge Heart second quarter 2010 total revenue decreases 18%: Cambridge Heart, Inc., today reported results for... http://bit.ly/9SiKrV
MarketWatch.com
marketwatch.com — “MarketWatch.com” View full resource at marketwatch.com
Most Recently Shared on August 17, 2010 at 2:18 am By:
Conmed Healthcare Management, Inc. Reports Second Quarter 2010 Financial Results: Total healthcare expenses for th... http://bit.ly/d66f8K
EntreMed second quarter 2010 net loss increases to $0.62 per share
news-medical.net — “EntreMed, Inc.,a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer, today reported financial results for the three and six-month periods ending June 30, 2010.” View full resource at news-medical.net
Most Recently Shared on August 16, 2010 at 4:58 pm By:
Ovarian Cancer News: EntreMed second quarter 2010 net loss increases to $0.62 per share: EntreMed, Inc.,a clini... http://buzzup.com/17103
Derma Sciences second-quarter net sales increase 14% to $13.2 million
news-medical.net — “Derma Sciences, Inc., a medical device and pharmaceutical company focused on advanced wound care, today reported financial and operating results for the three and six months ended June 30, 2010.” View full resource at news-medical.net
Most Recently Shared on August 13, 2010 at 12:35 pm By:
Derma Sciences second-quarter net sales increase 14% to $13.2 million: Derma Sciences, Inc., a medical device and ... http://bit.ly/9KPO3q
Neurologix second-quarter net loss increases to $4.5 million
news-medical.net — “Neurologix, Inc., a biotechnology company developing innovative gene therapies for the brain and central nervous system, today reported its financial results for the three and six months ended June 30, 2010.” View full resource at news-medical.net
Most Recently Shared on August 13, 2010 at 10:50 am By:
Parkinson's Disease: Neurologix second-quarter net loss increases to $4.5 million: Neurologix, Inc., a biotechnolo... http://bit.ly/bdR8OG
OXiGENE reports $2.5M net income for second-quarter 2010 vs. $5.3M net loss for same period in 2009
news-medical.net — “OXiGENE, Inc., a clinical-stage, biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases, reported financial results for the quarter and six months ended June 30, 2010, and presented an update on recent clinical and corporate progress.” View full resource at news-medical.net
Most Recently Shared on August 13, 2010 at 6:27 am By:
OXiGENE reports $2.5M net income for second-quarter 2010 vs. $5.3M net loss for same period in 2009: OXiGENE, Inc.... http://bit.ly/9XV815
Aeterna Zentaris second-quarter revenues decrease to $5.6 million
news-medical.net — “Aeterna Zentaris Inc., a late-stage drug development company specialized in oncology and endocrinology, today reported financial and operating results for the second quarter ended June 30, 2010.” View full resource at news-medical.net
Most Recently Shared on August 12, 2010 at 4:51 pm By:
Ovarian Cancer News: Aeterna Zentaris second-quarter revenues decrease to $5.6 million: Aeterna Zentaris Inc., ... http://buzzup.com/16k07
Protox reports $1.1M net income for second-quarter 2010 vs. $1.8M net loss for second-quarter 2009
news-medical.net — “Protox Therapeutics Inc., a leader in the development of receptor targeted fusion proteins, today released financial results for the second quarter 2010, ended June 30, 2010.” View full resource at news-medical.net
Most Recently Shared on August 11, 2010 at 4:45 pm By:
Prostate Cancer: Protox reports $1.1M net income for second-quarter 2010 vs. $1.8M net loss for second-quarter 200... http://bit.ly/b44vgo
ACADIA second-quarter net loss decreases to $4.3 million
news-medical.net — “ACADIA Pharmaceuticals Inc., a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders, today reported its unaudited financial results for the second quarter ended June 30, 2010.” View full resource at news-medical.net
Most Recently Shared on August 10, 2010 at 5:17 pm By:
Parkinson's Disease: ACADIA second-quarter net loss decreases to $4.3 million: ACADIA Pharmaceuticals Inc., a biop... http://bit.ly/aWQ4pn
Theragenics reports consolidated revenue of $20.8M for second-quarter 2010
news-medical.net — “Theragenics Corporation, a medical device company serving the surgical products and prostate cancer treatment markets, today announced consolidated financial results for the second quarter ended June 30, 2010.” View full resource at news-medical.net
Most Recently Shared on August 10, 2010 at 5:16 pm By:
Prostate Cancer: Theragenics reports consolidated revenue of $20.8M for second-quarter 2010: Theragenics Corporati... http://bit.ly/cjW7f9
Advertisement
